article thumbnail

Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years

Heart BMJ

The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. Women and more deprived groups had lower rates of SAVR (age-standardised rates per 100 000 in 2020–2023: 17.07 for men vs women; 9.82 for men vs women; 9.55 for IMD-1 vs IMD-5).

article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates. for SAVR vs. 0.4%

article thumbnail

Valsartan to Prevent Acquired Pulmonary Vein Stenosis in Pediatric Patients After Total Anomalous Pulmonary Venous Connection Surgery

Journal of the American Heart Association

BackgroundRecurrent pulmonary vein stenosis (PVS) following surgical repair of total anomalous pulmonary venous connection is associated with poor prognosis. Since August 2020, patients have been considered for valsartan therapy early after operation. Journal of the American Heart Association, Volume 14, Issue 4 , February 18, 2025.

article thumbnail

TAVR in Young Patients With Aortic Stenosis

JAMA Cardiology

American College of Cardiology/American Heart Association guideline recommendations for transcatheter aortic valve replacement (TAVR) transitioned in 2020 from decision-making based on estimated risk of surgical valve replacement (SAVR) to one based on patient age and expected longevity.

TAVR 40
article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

The primary safety endpoint was incidence of early onset (within seven days) primary adverse events; atrio-esophageal fistula (within 90 days); cardiac tamponade or perforation (within 30 days); and PV stenosis (within 12 months). Epub 2020 Jan 19. 2020 Jan 28;1747493020905964. 2020 June;127(1):4-20. Int J Stroke.

article thumbnail

See what happens when a left main thrombus evolves from subtotal occlusion to total occlusion.

Dr. Smith's ECG Blog

Below is a still image with the red arrow indicating the subtotal LMCA stenosis. Figure-1: Reasons for the varied ECG presentation of acute LMain occlusion — excerpted from Dr. Smith’s 8/9/2019 post ( This Table from My Comment in the January 16, 2020 post ). The video below shows the coronary angiography.

article thumbnail

What clinical scenario fits best?

Dr. Smith's ECG Blog

The following day in the cath lab a borderline significant mid LAD stenosis was found. At cath the following day there was a borderline significant stenosis of the mid LAD with FFR 0,8. We review ECG findings in Takotsubo Cardiomyopathy in the March 25, 2020 post of Dr. Smith's ECG Blog. Decision was made to stent the lesion.